Nov 08, 2017 14:01 pm UTC| Business
LOS ANGELES, Nov. 08, 2017 -- B. Riley FBR, Inc. (“B. Riley FBR”), a leading full service investment bank and wholly-owned subsidiary of B. Riley Financial, Inc. (NASDAQ:RILY), announced today that Rehan Rashid and...
Promethean Appoints Jaswir Singh as Chief Operating Officer
Nov 08, 2017 14:01 pm UTC| Business
Seattle, Wash., Nov. 08, 2017 -- PrometheanTM, a global education technology company, announced today the appointment of Jaswir Singh as the company’s Chief Operating Officer. ...
The Trade Desk Enhances Targeting Capabilities With Carrier-Level Data from Pinsight Media
Nov 08, 2017 14:01 pm UTC| Business
LOS ANGELES, Nov. 08, 2017 -- The Trade Desk, Inc. (NASDAQ:TTD), a global technology platform for buyers of advertising, today announced its collaboration with Pinsight, a leader in mobile analytics, media and mobile...
P.A.M. Transportation Services, Inc. Announces Preliminary Results of its Self Tender Offer
Nov 08, 2017 14:01 pm UTC| Business
TONTITOWN, Ark., Nov. 08, 2017 -- P.A.M. Transportation Services, Inc. (NASDAQ:PTSI) (the “Company” or “PTSI”) today announced the preliminary results of its modified “Dutch auction” tender offer to repurchase up to...
Druva Introduces Next Generation Cloud-to-Cloud Data Protection with Apollo for AWS
Nov 08, 2017 14:01 pm UTC| Business
SUNNYVALE, Calif., Nov. 08, 2017 -- Today, Druva announced Druva Apollo a new service delivered via the Druva Cloud Platform that enables data management for Infrastructure-as-a-Service (IaaS) and Platform-as-a-Service...
Nov 08, 2017 14:01 pm UTC| Business
LOS ANGELES, Nov. 08, 2017 -- Collab9, a best-of-breed, FedRAMPSM Authorized Unified Communications as a Service (UCaaS) provider, today announced that it has partnered with the United States Customs and Border...
Nov 08, 2017 14:01 pm UTC| Business
ROCKVILLE, Md., Nov. 08, 2017 -- Rexahn Pharmaceuticals, Inc. (NYSE AMERICAN:RNN), today announced that it has dosed the first patient in a Phase IIa clinical study of RX-3117 in combination with Abraxane® in patients...